Article
Normalization of sweat chloride concentration and clinical improvement with ivacaftor in a patient with cystic fibrosis with mutation S549N.
Chest - 1 Oct 2013
McGarry Meghan E, Nielson Dennis W
Abstract excerpt
The cystic fibrosis (CF) protein forms an anion channel in epithelial cells, and the absence or defective function of this channel results in the clinical manifestations of CF. CF is an autosomal recessive disorder, and its many disease-causing mutations divide into five or six classes. There are 10 known class 3 gating mutations, the most common of which is G551D. Ivacaftor is a drug that in vitro increases open...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
